| Code | Description | Claims | Beneficiaries | Total Paid |
|---|
| 99214 |
Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity |
109,312 |
102,448 |
$8.61M |
| 99284 |
Emergency department visit for the evaluation and management, high severity |
27,639 |
25,579 |
$5.88M |
| G0463 |
Hospital outpatient clinic visit for assessment and management of a patient |
69,165 |
57,227 |
$5.75M |
| 99285 |
Emergency department visit for the evaluation and management, high severity with immediate threat to life |
15,619 |
14,231 |
$4.44M |
| 99283 |
Emergency department visit for the evaluation and management, moderate severity |
26,478 |
25,051 |
$4.14M |
| 99213 |
Office or other outpatient visit for the evaluation and management of an established patient, low complexity |
79,323 |
73,045 |
$4.12M |
| 74177 |
Computed tomography, abdomen and pelvis; with contrast material |
7,190 |
6,844 |
$2.41M |
| 70450 |
Computed tomography, head or brain; without contrast material |
7,651 |
7,195 |
$1.47M |
| 93005 |
Electrocardiogram, routine ECG with at least 12 leads; tracing only, without interpretation and report |
22,631 |
19,967 |
$1.31M |
| 93306 |
Echocardiography, transthoracic, real-time with image documentation, with and without Doppler, complete |
6,731 |
6,261 |
$1.20M |
| 80053 |
Comprehensive metabolic panel |
58,225 |
49,412 |
$1.18M |
| 96374 |
Therapeutic, prophylactic, or diagnostic injection; intravenous push, single or initial substance |
19,409 |
16,927 |
$1.02M |
| 11043 |
|
9,622 |
3,484 |
$961K |
| 71045 |
Radiologic examination, chest; single view |
20,066 |
18,489 |
$885K |
| 96375 |
Therapeutic injection; each additional sequential IV push |
16,439 |
14,009 |
$869K |
| G0378 |
Hospital observation service, per hour |
3,210 |
1,972 |
$816K |
| 96365 |
Intravenous infusion, for therapy, prophylaxis, or diagnosis; initial, up to 1 hour |
8,333 |
6,606 |
$796K |
| 87631 |
|
8,184 |
7,710 |
$792K |
| 99391 |
Periodic comprehensive preventive medicine reevaluation, established patient, infant (under 1 year) |
7,491 |
6,565 |
$783K |
| 96361 |
Intravenous infusion, hydration; each additional hour |
19,397 |
16,822 |
$770K |
| 78452 |
Myocardial perfusion imaging, tomographic (SPECT); multiple studies at rest and/or stress |
1,872 |
1,702 |
$756K |
| 87635 |
Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe |
18,907 |
17,322 |
$744K |
| 85025 |
Blood count; complete (CBC), automated, and automated differential WBC count |
62,066 |
52,070 |
$733K |
| 87502 |
Infectious agent detection by nucleic acid, influenza virus, for multiple types or subtypes, includes all targets |
9,869 |
9,393 |
$731K |
| 74176 |
Computed tomography, abdomen and pelvis; without contrast material |
2,664 |
2,528 |
$607K |
| G0480 |
Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms (any type, single or tandem and excluding immunoassays (e.g., ia, eia, elisa, emit, fpia) and enzymatic methods (e.g., alcohol dehydrogenase)), (2) stable isotope or other universally recognized internal standards in all samples (e.g., to control for matrix effects, interferences and variations in signal strength), and (3) method or drug-specific calibration and matrix-matched quality control material (e.g., to control for instrument variations and mass spectral drift); qualitative or quantitative, all sources, includes specimen validity testing, per day; 1-7 drug class(es), including metabolite(s) if performed |
7,418 |
6,638 |
$521K |
| 90853 |
Group psychotherapy (other than of a multiple-family group) |
4,731 |
1,220 |
$508K |
| 99392 |
Periodic comprehensive preventive medicine reevaluation, established patient, early childhood (1-4 years) |
4,799 |
4,733 |
$501K |
| 43239 |
Esophagogastroduodenoscopy, flexible, transoral; with biopsy, single or multiple |
1,613 |
1,446 |
$496K |
| 87804 |
Infectious agent antigen detection by immunoassay; Influenza, each type |
28,693 |
15,550 |
$466K |
| 94640 |
Pressurized or nonpressurized inhalation treatment for acute airway obstruction |
4,045 |
2,980 |
$466K |
| 71275 |
Computed tomographic angiography, chest, with contrast material |
1,598 |
1,541 |
$452K |
| 72125 |
Computed tomography, cervical spine; without contrast material |
2,273 |
2,170 |
$442K |
| 87880 |
Infectious agent antigen detection by immunoassay; Streptococcus, group A |
27,599 |
26,370 |
$435K |
| 0241U |
Neonatal screening for hereditary disorders, genomic sequence analysis panel |
3,069 |
2,854 |
$430K |
| 99215 |
Prolong outpt/office vis |
4,471 |
4,070 |
$395K |
| 99282 |
Emergency department visit for the evaluation and management, low to moderate severity |
4,114 |
3,909 |
$389K |
| 88305 |
Level IV - Surgical pathology, gross and microscopic examination |
6,713 |
6,504 |
$389K |
| 95811 |
|
853 |
763 |
$368K |
| 87426 |
Infectious agent antigen detection, SARS-CoV-2 (COVID-19) |
10,328 |
9,494 |
$357K |
| 71046 |
Radiologic examination, chest; 2 views |
5,616 |
5,402 |
$355K |
| 99232 |
Subsequent hospital care, per day, moderate complexity |
6,432 |
2,890 |
$341K |
| 96360 |
Intravenous infusion, hydration; initial, 31 minutes to 1 hour |
4,677 |
4,329 |
$323K |
| 96372 |
Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular |
11,669 |
10,235 |
$316K |
| C9803 |
Hospital outpatient clinic visit specimen collection for severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), any specimen source |
15,599 |
14,237 |
$316K |
| 84443 |
Thyroid stimulating hormone (TSH) |
13,123 |
12,473 |
$287K |
| 87651 |
Infectious agent detection by nucleic acid; Streptococcus, group A, amplified probe |
6,923 |
6,701 |
$284K |
| 99204 |
Office or other outpatient visit for the evaluation and management of a new patient, moderate complexity |
2,607 |
2,497 |
$270K |
| 36415 |
Collection of venous blood by venipuncture |
62,160 |
51,770 |
$265K |
| 71260 |
Computed tomography, thorax, diagnostic; with contrast material |
1,051 |
1,009 |
$262K |
| 76816 |
Ultrasound, pregnant uterus, real time with image documentation, follow-up |
3,183 |
2,440 |
$260K |
| 90834 |
Psychotherapy, 45 minutes with patient |
1,611 |
1,060 |
$259K |
| 76805 |
Ultrasound, pregnant uterus, real time with image documentation, fetal and maternal evaluation |
2,865 |
2,467 |
$249K |
| 90471 |
Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections), 1 vaccine |
13,625 |
13,315 |
$235K |
| 99203 |
Office or other outpatient visit for the evaluation and management of a new patient, low complexity |
2,997 |
2,922 |
$235K |
| 93010 |
Electrocardiogram, routine ECG with at least 12 leads; interpretation and report only |
31,113 |
26,416 |
$222K |
| 90472 |
Immunization administration, each additional vaccine (list separately) |
7,547 |
7,388 |
$219K |
| 99442 |
|
2,952 |
2,780 |
$216K |
| 93017 |
|
1,577 |
1,529 |
$214K |
| 73562 |
|
2,089 |
2,019 |
$208K |
| 84484 |
|
13,101 |
10,029 |
$205K |
| 95810 |
Polysomnography; sleep staging with 4 or more additional parameters |
409 |
375 |
$196K |
| 90792 |
Psychiatric diagnostic evaluation with medical services |
1,609 |
1,389 |
$193K |
| 76830 |
Ultrasound, transvaginal |
1,666 |
1,547 |
$187K |
| 73610 |
|
1,794 |
1,674 |
$187K |
| 64635 |
|
384 |
344 |
$178K |
| 81001 |
|
31,660 |
28,715 |
$173K |
| 99231 |
Subsequent hospital care, per day, straightforward or low complexity |
4,637 |
2,021 |
$169K |
| 76801 |
|
1,737 |
1,465 |
$169K |
| 64493 |
|
544 |
491 |
$167K |
| 73130 |
|
2,200 |
2,036 |
$166K |
| 11042 |
Debridement, subcutaneous tissue (includes epidermis, dermis, and subcutaneous tissue); first 20 sq cm |
1,867 |
945 |
$166K |
| 83690 |
|
13,009 |
11,873 |
$165K |
| 99393 |
Periodic comprehensive preventive medicine reevaluation, established patient, late childhood (5-11 years) |
1,589 |
1,552 |
$165K |
| 76705 |
Ultrasound, abdominal, real time with image documentation; limited |
1,757 |
1,714 |
$162K |
| 73030 |
|
2,001 |
1,887 |
$156K |
| 87428 |
|
2,186 |
2,153 |
$151K |
| 99212 |
Office or other outpatient visit for the evaluation and management of an established patient, straightforward |
4,158 |
4,015 |
$147K |
| 45380 |
Colonoscopy, flexible; with biopsy, single or multiple |
370 |
354 |
$146K |
| 73630 |
|
1,902 |
1,845 |
$140K |
| 82306 |
Vitamin D; 25 hydroxy, includes fraction(s), if performed |
4,791 |
4,713 |
$134K |
| 87086 |
Culture, bacterial; quantitative colony count, urine |
9,796 |
8,978 |
$131K |
| 80306 |
|
9,239 |
8,464 |
$129K |
| 59025 |
Fetal non-stress test |
1,498 |
1,082 |
$121K |
| 72100 |
|
1,356 |
1,333 |
$118K |
| 64636 |
|
592 |
330 |
$113K |
| 71250 |
|
713 |
676 |
$113K |
| 80061 |
Lipid panel |
6,681 |
6,558 |
$111K |
| 64483 |
|
407 |
349 |
$109K |
| 99443 |
|
1,034 |
981 |
$109K |
| Q9967 |
Low osmolar contrast material, 300-399 mg/ml iodine concentration, per ml |
10,387 |
9,730 |
$102K |
| 84703 |
|
7,903 |
7,373 |
$102K |
| 76856 |
Ultrasound, pelvic (nonobstetric), real time with image documentation; complete |
852 |
817 |
$97K |
| 73110 |
|
1,466 |
1,315 |
$94K |
| 96366 |
Intravenous infusion, for therapy, prophylaxis, or diagnosis; each additional hour |
1,674 |
1,306 |
$94K |
| 83605 |
|
4,967 |
4,307 |
$89K |
| 93971 |
|
920 |
883 |
$87K |
| 99233 |
Prolong inpt eval add15 m |
1,089 |
508 |
$83K |
| 87070 |
|
5,307 |
5,092 |
$81K |
| A9502 |
Technetium tc-99m tetrofosmin, diagnostic, per study dose |
1,027 |
990 |
$79K |
| 72131 |
|
306 |
295 |
$77K |
| 83880 |
|
3,754 |
3,447 |
$77K |
| 90960 |
End-stage renal disease related services monthly, for patients 20 years and older, with 4 or more face-to-face visits |
1,635 |
1,581 |
$76K |
| 77067 |
Screening mammography, bilateral, including computer-aided detection |
455 |
448 |
$71K |
| 70486 |
|
372 |
359 |
$68K |
| 99177 |
|
1,831 |
1,802 |
$66K |
| 87641 |
|
2,365 |
2,036 |
$66K |
| 83036 |
Hemoglobin; glycosylated (A1C) |
6,596 |
6,448 |
$65K |
| 99223 |
Prolong inpt eval add15 m |
409 |
395 |
$65K |
| 85610 |
|
11,725 |
9,605 |
$64K |
| 64494 |
|
584 |
423 |
$63K |
| 99309 |
Subsequent nursing facility care, per day, low to moderate complexity |
2,026 |
1,659 |
$62K |
| 87040 |
|
4,125 |
2,849 |
$61K |
| 94726 |
|
578 |
540 |
$56K |
| 94060 |
|
699 |
651 |
$55K |
| 86140 |
|
5,578 |
5,181 |
$55K |
| 99239 |
Hospital discharge day management, more than 30 minutes |
553 |
527 |
$54K |
| 93000 |
|
4,937 |
4,704 |
$51K |
| 90791 |
Psychiatric diagnostic evaluation |
334 |
324 |
$51K |
| 74021 |
|
410 |
395 |
$49K |
| 81025 |
|
5,323 |
5,111 |
$49K |
| 73721 |
Magnetic resonance imaging, any joint of lower extremity; without contrast material |
146 |
136 |
$48K |
| 87807 |
|
3,640 |
3,464 |
$48K |
| 74018 |
|
681 |
659 |
$47K |
| 99308 |
Subsequent nursing facility care, per day, straightforward |
2,699 |
2,198 |
$46K |
| 80048 |
Basic metabolic panel (calcium, ionized) |
3,481 |
3,158 |
$43K |
| 87186 |
|
4,875 |
4,563 |
$42K |
| 86900 |
|
2,858 |
2,645 |
$41K |
| J2704 |
Injection, propofol, 10 mg |
7,006 |
6,650 |
$40K |
| J7040 |
Infusion, normal saline solution, sterile (500 ml = 1 unit) |
2,285 |
1,934 |
$39K |
| 83735 |
|
4,754 |
3,754 |
$38K |
| 20610 |
|
919 |
847 |
$38K |
| 96376 |
|
2,595 |
2,171 |
$36K |
| 90474 |
|
2,134 |
2,095 |
$36K |
| J7050 |
Infusion, normal saline solution, 250 cc |
1,791 |
1,345 |
$36K |
| 87591 |
Infectious agent detection by nucleic acid; Neisseria gonorrhoeae, amplified probe |
1,035 |
996 |
$36K |
| 87491 |
Infectious agent detection by nucleic acid; Chlamydia trachomatis, amplified probe |
1,036 |
996 |
$36K |
| 73560 |
|
1,049 |
888 |
$35K |
| J2785 |
Injection, regadenoson, 0.1 mg |
558 |
542 |
$35K |
| 86850 |
|
2,347 |
2,213 |
$35K |
| 87077 |
|
4,941 |
4,632 |
$34K |
| 87640 |
|
1,210 |
971 |
$33K |
| 99173 |
|
1,246 |
1,207 |
$32K |
| 76817 |
Ultrasound, pregnant uterus, real time with image documentation, transvaginal |
317 |
277 |
$32K |
| 84702 |
|
1,414 |
1,091 |
$31K |
| 73502 |
|
628 |
589 |
$31K |
| 99441 |
|
642 |
611 |
$29K |
| 76815 |
Ultrasound, pregnant uterus, real time with image documentation, limited |
472 |
346 |
$29K |
| G0260 |
Injection procedure for sacroiliac joint; provision of anesthetic, steroid and/or other therapeutic agent, with or without arthrography |
81 |
80 |
$28K |
| 96413 |
Chemotherapy administration, intravenous infusion; up to 1 hour, single or initial substance |
91 |
49 |
$28K |
| 72148 |
Magnetic resonance imaging, lumbar spine; without contrast material |
79 |
76 |
$28K |
| 99238 |
Hospital discharge day management, 30 minutes or less |
460 |
446 |
$27K |
| 90832 |
Psychotherapy, 30 minutes with patient |
160 |
121 |
$27K |
| 82607 |
|
1,788 |
1,749 |
$27K |
| 90837 |
Psychotherapy, 53 minutes with patient |
212 |
141 |
$26K |
| 99394 |
Periodic comprehensive preventive medicine reevaluation, established patient, adolescent (12-17 years) |
239 |
232 |
$25K |
| 86769 |
|
1,080 |
920 |
$25K |
| 99291 |
Critical care, evaluation and management of the critically ill patient, first 30-74 minutes |
56 |
56 |
$25K |
| 82550 |
|
1,463 |
1,291 |
$25K |
| 99395 |
Periodic comprehensive preventive medicine reevaluation, established patient, 18-39 years |
246 |
246 |
$25K |
| M0243 |
Intravenous infusion or subcutaneous injection, casirivimab and imdevimab includes infusion or injection, and post administration monitoring |
108 |
107 |
$25K |
| 84439 |
|
2,207 |
2,129 |
$23K |
| 72040 |
|
269 |
266 |
$23K |
| 76700 |
Ultrasound, abdominal, real time with image documentation; complete |
184 |
178 |
$22K |
| 73565 |
|
580 |
512 |
$21K |
| 76813 |
|
342 |
313 |
$21K |
| 82728 |
|
1,361 |
1,315 |
$21K |
| 36591 |
|
614 |
316 |
$21K |
| 85379 |
|
1,649 |
1,579 |
$20K |
| J1100 |
Injection, dexamethasone sodium phosphate, 1 mg |
5,104 |
4,608 |
$20K |
| J1885 |
Injection, ketorolac tromethamine, per 15 mg |
8,782 |
7,847 |
$20K |
| 96367 |
|
573 |
489 |
$20K |
| 94729 |
|
596 |
551 |
$18K |
| 76641 |
|
138 |
136 |
$18K |
| J0696 |
Injection, ceftriaxone sodium, per 250 mg |
3,145 |
2,561 |
$18K |
| 99211 |
Office or other outpatient visit for the evaluation and management of an established patient, minimal severity |
1,754 |
1,606 |
$17K |
| 82962 |
|
6,561 |
3,828 |
$17K |
| J7030 |
Infusion, normal saline solution , 1000 cc |
14,612 |
12,421 |
$17K |
| 11046 |
|
74 |
40 |
$16K |
| 92551 |
|
1,427 |
1,389 |
$16K |
| 88342 |
|
444 |
435 |
$16K |
| 82803 |
|
495 |
401 |
$16K |
| 99205 |
Prolong outpt/office vis |
126 |
120 |
$16K |
| 83550 |
|
1,512 |
1,470 |
$16K |
| J2001 |
Injection, lidocaine hcl for intravenous infusion, 10 mg |
13,024 |
7,906 |
$15K |
| J1050 |
Injection, medroxyprogesterone acetate, 1 mg |
268 |
267 |
$15K |
| 73080 |
|
266 |
260 |
$15K |
| 83970 |
|
616 |
594 |
$15K |
| 77063 |
Screening digital breast tomosynthesis, bilateral |
453 |
446 |
$15K |
| 93016 |
|
971 |
953 |
$14K |
| 64484 |
|
147 |
101 |
$14K |
| 86592 |
|
1,848 |
1,825 |
$14K |
| 76536 |
|
118 |
115 |
$14K |
| 88307 |
|
165 |
158 |
$13K |
| 86703 |
|
964 |
954 |
$13K |
| J0131 |
Injection, acetaminophen, not otherwise specified,10 mg |
2,678 |
2,465 |
$13K |
| J3301 |
Injection, triamcinolone acetonide, not otherwise specified, 10 mg |
3,041 |
2,815 |
$13K |
| 96110 |
Developmental screening, with scoring and documentation, per standardized instrument |
713 |
657 |
$13K |
| 36600 |
|
399 |
369 |
$13K |
| 73090 |
|
154 |
135 |
$13K |
| 99245 |
|
57 |
57 |
$13K |
| 85652 |
|
2,090 |
1,915 |
$13K |
| 85730 |
|
1,767 |
1,652 |
$12K |
| 87653 |
|
292 |
291 |
$12K |
| 73140 |
|
207 |
179 |
$12K |
| 84436 |
|
1,334 |
1,297 |
$11K |
| 97602 |
|
186 |
102 |
$11K |
| 83540 |
|
1,309 |
1,281 |
$11K |
| 88304 |
|
839 |
813 |
$11K |
| 01935 |
|
139 |
139 |
$11K |
| 77066 |
Tomosynthesis, mammo |
69 |
63 |
$11K |
| 99460 |
|
121 |
119 |
$11K |
| 81002 |
|
5,191 |
4,998 |
$11K |
| 84153 |
|
573 |
559 |
$11K |
| 87389 |
Infectious agent antigen detection by immunoassay technique, HIV-1 antigen with HIV-1 and HIV-2 antibodies |
597 |
591 |
$11K |
| 86803 |
|
472 |
466 |
$10K |
| 76770 |
|
91 |
88 |
$10K |
| 99244 |
Office or other outpatient consultation, moderate to high complexity |
60 |
60 |
$10K |
| 90715 |
|
598 |
587 |
$10K |
| 82570 |
|
1,418 |
1,362 |
$9K |
| 93018 |
|
971 |
953 |
$9K |
| 87340 |
|
772 |
763 |
$9K |
| 80074 |
|
229 |
219 |
$9K |
| 72110 |
|
92 |
92 |
$9K |
| 82043 |
|
1,126 |
1,091 |
$9K |
| 87205 |
|
1,957 |
1,793 |
$8K |
| J2405 |
Injection, ondansetron hydrochloride, per 1 mg |
12,139 |
10,459 |
$8K |
| 70491 |
|
25 |
24 |
$8K |
| 86038 |
|
475 |
465 |
$8K |
| C9290 |
Injection, bupivacaine liposome, 1 mg |
719 |
671 |
$8K |
| 93976 |
|
51 |
50 |
$8K |
| J1815 |
Injection, insulin, per 5 units |
562 |
304 |
$7K |
| 01992 |
|
72 |
71 |
$7K |
| G0279 |
Diagnostic digital breast tomosynthesis, unilateral or bilateral (list separately in addition to 77065 or 77066) |
184 |
173 |
$7K |
| 82140 |
|
495 |
449 |
$7K |
| 95165 |
Professional services for the supervision of preparation and provision of antigens for allergen immunotherapy, multiple dose vials |
15 |
12 |
$7K |
| 64495 |
|
85 |
65 |
$6K |
| 97530 |
Therapeutic activities, direct patient contact, each 15 minutes |
205 |
80 |
$6K |
| 45378 |
Colonoscopy, flexible; diagnostic, including collection of specimen(s) |
13 |
13 |
$6K |
| 80305 |
|
550 |
518 |
$6K |
| 86756 |
|
310 |
297 |
$6K |
| J0561 |
Injection, penicillin g benzathine, 100,000 units |
70 |
68 |
$6K |
| 95251 |
|
207 |
204 |
$6K |
| 82150 |
|
463 |
441 |
$5K |
| J3490 |
Unclassified drugs |
1,596 |
1,363 |
$5K |
| J0690 |
Injection, cefazolin sodium, 500 mg |
2,020 |
1,774 |
$5K |
| 73700 |
|
26 |
26 |
$5K |
| 73523 |
|
27 |
27 |
$5K |
| 84100 |
|
831 |
733 |
$5K |
| 80076 |
|
497 |
482 |
$5K |
| 99396 |
Periodic comprehensive preventive medicine reevaluation, established patient, 40-64 years |
61 |
57 |
$5K |
| 84480 |
|
337 |
331 |
$5K |
| 82746 |
|
340 |
327 |
$5K |
| J2930 |
Injection, methylprednisolone sodium succinate, up to 125 mg |
1,245 |
1,146 |
$5K |
| 12001 |
|
48 |
48 |
$5K |
| J3010 |
Injection, fentanyl citrate, 0.1 mg |
6,924 |
6,194 |
$5K |
| M0245 |
Intravenous infusion, bamlanivimab and etesevimab, includes infusion and post administration monitoring |
13 |
13 |
$5K |
| 85018 |
|
1,353 |
1,287 |
$5K |
| 86762 |
|
355 |
352 |
$5K |
| 93225 |
|
69 |
68 |
$5K |
| 85014 |
|
1,352 |
1,291 |
$5K |
| 83516 |
|
105 |
95 |
$5K |
| 93226 |
|
69 |
68 |
$5K |
| 73590 |
|
70 |
67 |
$4K |
| 90686 |
|
2,602 |
2,587 |
$4K |
| 97110 |
Therapeutic procedure, each 15 minutes; therapeutic exercises to develop strength and endurance, flexibility and range of motion |
89 |
26 |
$4K |
| 72070 |
|
54 |
53 |
$4K |
| 87634 |
|
63 |
63 |
$4K |
| 01936 |
|
59 |
54 |
$4K |
| 99218 |
|
56 |
49 |
$4K |
| 82950 |
|
646 |
645 |
$4K |
| 84550 |
|
623 |
598 |
$4K |
| 93970 |
|
28 |
26 |
$4K |
| 96127 |
|
607 |
573 |
$4K |
| 84479 |
|
465 |
449 |
$4K |
| J2270 |
Injection, morphine sulfate, up to 10 mg |
4,564 |
3,833 |
$4K |
| 72050 |
|
40 |
39 |
$4K |
| G2211 |
Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's single, serious condition or a complex condition. (add-on code, list separately in addition to office/outpatient evaluation and management visit, new or established) |
235 |
217 |
$4K |
| 84481 |
|
174 |
171 |
$3K |
| 96161 |
|
789 |
647 |
$3K |
| 74022 |
|
27 |
27 |
$3K |
| J1642 |
Injection, heparin sodium, (heparin lock flush), per 10 units |
2,924 |
992 |
$3K |
| J2250 |
Injection, midazolam hydrochloride, per 1 mg |
3,912 |
3,633 |
$3K |
| 87522 |
Neg quan hep c or qual rna |
54 |
52 |
$3K |
| 99383 |
|
17 |
17 |
$3K |
| 84145 |
|
194 |
192 |
$3K |
| 82248 |
|
427 |
270 |
$3K |
| 12002 |
|
26 |
26 |
$3K |
| 96160 |
|
1,053 |
589 |
$3K |
| 0001A |
|
69 |
66 |
$3K |
| 0071A |
|
68 |
68 |
$3K |
| G0444 |
Annual depression screening, 5 to 15 minutes |
165 |
159 |
$3K |
| 70498 |
|
13 |
13 |
$3K |
| 0002A |
|
63 |
63 |
$3K |
| 86780 |
|
221 |
215 |
$2K |
| 99496 |
|
24 |
24 |
$2K |
| 96368 |
|
145 |
126 |
$2K |
| 85027 |
|
285 |
270 |
$2K |
| 95886 |
|
24 |
24 |
$2K |
| 27096 |
|
21 |
21 |
$2K |
| 82247 |
|
317 |
168 |
$2K |
| 70496 |
|
13 |
12 |
$2K |
| 10060 |
|
14 |
13 |
$2K |
| 71101 |
|
25 |
25 |
$2K |
| 95812 |
|
30 |
24 |
$2K |
| 0072A |
|
40 |
40 |
$2K |
| 86431 |
|
228 |
226 |
$2K |
| 86003 |
|
16 |
12 |
$1K |
| 94618 |
|
13 |
13 |
$1K |
| 73564 |
|
98 |
93 |
$1K |
| 86308 |
|
172 |
168 |
$1K |
| 87210 |
|
256 |
253 |
$1K |
| 29125 |
|
12 |
12 |
$1K |
| J1200 |
Injection, diphenhydramine hcl, up to 50 mg |
2,322 |
2,089 |
$1K |
| 76981 |
|
14 |
13 |
$1K |
| 82784 |
|
83 |
78 |
$1K |
| 86376 |
|
97 |
97 |
$1K |
| 72170 |
|
18 |
18 |
$1K |
| 99318 |
|
71 |
70 |
$1K |
| 87493 |
|
40 |
37 |
$1K |
| 83655 |
|
68 |
67 |
$1K |
| J2060 |
Injection, lorazepam, 2 mg |
1,988 |
1,753 |
$1K |
| 88142 |
|
504 |
484 |
$1K |
| 90688 |
|
55 |
53 |
$935.61 |
| 77089 |
|
39 |
37 |
$926.28 |
| 99406 |
|
102 |
100 |
$893.74 |
| 90961 |
|
41 |
40 |
$870.12 |
| 80055 |
|
13 |
13 |
$831.28 |
| 73070 |
|
17 |
13 |
$816.13 |
| Q0162 |
Ondansetron 1 mg, oral, fda approved prescription anti-emetic, for use as a complete therapeutic substitute for an iv anti-emetic at the time of chemotherapy treatment, not to exceed a 48 hour dosage regimen |
67 |
60 |
$785.22 |
| 20611 |
|
12 |
12 |
$776.72 |
| 83013 |
|
12 |
12 |
$774.96 |
| J1170 |
Injection, hydromorphone, up to 4 mg |
1,199 |
969 |
$706.62 |
| 73060 |
|
12 |
12 |
$682.05 |
| 90756 |
|
133 |
130 |
$591.60 |
| 83721 |
|
93 |
92 |
$590.05 |
| 88300 |
|
35 |
35 |
$572.83 |
| 99281 |
Emergency department visit for the evaluation and management, self-limited or minor |
14 |
12 |
$554.18 |
| 80069 |
|
26 |
25 |
$478.46 |
| J2550 |
Injection, promethazine hcl, up to 50 mg |
600 |
517 |
$475.74 |
| 90670 |
|
2,746 |
2,725 |
$472.11 |
| 99459 |
|
33 |
31 |
$462.86 |
| 99072 |
|
41 |
41 |
$460.00 |
| 90633 |
|
1,025 |
1,018 |
$453.80 |
| Q0091 |
Screening papanicolaou smear; obtaining, preparing and conveyance of cervical or vaginal smear to laboratory |
330 |
320 |
$446.67 |
| 0073A |
|
13 |
13 |
$440.00 |
| J2765 |
Injection, metoclopramide hcl, up to 10 mg |
673 |
623 |
$388.62 |
| J0330 |
Injection, succinylcholine chloride, up to 20 mg |
255 |
202 |
$379.04 |
| 84403 |
|
12 |
12 |
$373.68 |
| 90648 |
|
1,177 |
1,164 |
$352.94 |
| 93227 |
|
14 |
14 |
$341.03 |
| 99307 |
|
16 |
14 |
$336.28 |
| 80164 |
|
18 |
14 |
$329.16 |
| 51702 |
|
12 |
12 |
$326.49 |
| J2360 |
Injection, orphenadrine citrate, up to 60 mg |
142 |
137 |
$324.18 |
| 96380 |
|
17 |
15 |
$276.90 |
| 84146 |
|
12 |
12 |
$225.16 |
| 90671 |
|
342 |
335 |
$189.86 |
| C1887 |
Catheter, guiding (may include infusion/perfusion capability) |
12 |
12 |
$185.69 |
| 86580 |
|
24 |
24 |
$184.03 |
| J7120 |
Ringers lactate infusion, up to 1000 cc |
742 |
669 |
$170.74 |
| J7510 |
Prednisolone oral, per 5 mg |
138 |
132 |
$163.69 |
| 90680 |
|
2,027 |
2,008 |
$158.12 |
| 94760 |
|
17 |
14 |
$154.83 |
| 87045 |
|
12 |
12 |
$147.72 |
| J1644 |
Injection, heparin sodium, per 1000 units |
321 |
176 |
$143.27 |
| J3360 |
Injection, diazepam, up to 5 mg |
105 |
88 |
$121.45 |
| J2919 |
Injection, methylprednisolone sodium succinate, 5 mg |
192 |
176 |
$119.47 |
| J2543 |
Injection, piperacillin sodium/tazobactam sodium, 1 gram/0.125 grams (1.125 grams) |
153 |
125 |
$116.49 |
| 88302 |
|
12 |
12 |
$109.48 |
| 83037 |
|
12 |
12 |
$106.47 |
| A9585 |
Injection, gadobutrol, 0.1 ml |
46 |
32 |
$90.17 |
| 90619 |
|
13 |
13 |
$74.90 |
| A4216 |
Sterile water, saline and/or dextrose, diluent/flush, 10 ml |
34 |
33 |
$70.40 |
| 90716 |
|
12 |
12 |
$68.94 |
| 90707 |
|
24 |
24 |
$68.94 |
| 91307 |
|
118 |
118 |
$40.00 |
| 91300 |
|
131 |
117 |
$40.00 |
| J0780 |
Injection, prochlorperazine, up to 10 mg |
116 |
114 |
$37.92 |
| J3370 |
Injection, vancomycin hcl, 500 mg |
43 |
37 |
$32.60 |
| J3475 |
Injection, magnesium sulfate, per 500 mg |
54 |
50 |
$30.25 |
| J7644 |
Ipratropium bromide, inhalation solution, fda-approved final product, non-compounded, administered through dme, unit dose form, per milligram |
166 |
155 |
$29.46 |
| G0008 |
Administration of influenza virus vaccine |
33 |
32 |
$24.00 |
| Q2035 |
Influenza virus vaccine, split virus, when administered to individuals 3 years of age and older, for intramuscular use (afluria) |
16 |
15 |
$18.24 |
| J3480 |
Injection, potassium chloride, per 2 meq |
16 |
12 |
$16.41 |
| J7620 |
Albuterol, up to 2.5 mg and ipratropium bromide, up to 0.5 mg, fda-approved final product, non-compounded, administered through dme |
138 |
133 |
$13.93 |
| J1940 |
Injection, furosemide, up to 20 mg |
23 |
12 |
$9.64 |
| J2003 |
Injection, lidocaine hydrochloride, 1 mg |
218 |
134 |
$8.35 |
| J7613 |
Albuterol, inhalation solution, fda-approved final product, non-compounded, administered through dme, unit dose, 1 mg |
152 |
140 |
$8.07 |
| J2710 |
Injection, neostigmine methylsulfate, up to 0.5 mg |
12 |
12 |
$8.00 |
| J1790 |
Injection, droperidol, up to 5 mg |
14 |
12 |
$5.15 |
| Q0245 |
Injection, bamlanivimab and etesevimab, 2100 mg |
14 |
14 |
$0.90 |
| 90723 |
|
956 |
945 |
$0.00 |
| G8754 |
Most recent diastolic blood pressure < 90 mmhg |
336 |
328 |
$0.00 |
| 90697 |
|
167 |
167 |
$0.00 |
| 90651 |
|
75 |
74 |
$0.00 |
| 90677 |
|
554 |
552 |
$0.00 |
| G8883 |
Biopsy results reviewed, communicated, tracked and documented |
13 |
13 |
$0.00 |
| 90698 |
|
359 |
359 |
$0.00 |
| 1111F |
|
2,225 |
2,136 |
$0.00 |
| 90656 |
|
240 |
240 |
$0.00 |
| 3008F |
|
30 |
29 |
$0.00 |
| 90696 |
|
62 |
62 |
$0.00 |
| G8510 |
Screening for depression is documented as negative, a follow-up plan is not required |
14 |
12 |
$0.00 |
| G8708 |
Patient not prescribed antibiotic |
28 |
27 |
$0.00 |
| 90710 |
|
52 |
52 |
$0.00 |
| G8482 |
Influenza immunization administered or previously received |
29 |
29 |
$0.00 |
| G1004 |
Clinical decision support mechanism national decision support company, as defined by the medicare appropriate use criteria program |
1,729 |
1,649 |
$0.00 |
| 1160F |
|
58 |
54 |
$0.00 |
| 90685 |
|
99 |
94 |
$0.00 |
| 90734 |
|
59 |
59 |
$0.00 |
| G8752 |
Most recent systolic blood pressure < 140 mmhg |
139 |
136 |
$0.00 |
| G8483 |
Influenza immunization was not administered for reasons documented by clinician (e.g., patient allergy or other medical reasons, patient declined or other patient reasons, vaccine not available or other system reasons) |
38 |
38 |
$0.00 |
| 90966 |
|
36 |
36 |
$0.00 |
| 1159F |
|
58 |
54 |
$0.00 |
| 90380 |
|
15 |
15 |
$0.00 |